The vitamin D receptor turns off chronically activated T cells

Annals of the New York Academy of Sciences

Volumn 1317, Issue 1, 2014, Pages 70-75

  Cantorna, Margherita T ^a   Waddell, Amanda ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

CD8 T cells; Inflammatory bowel diseases; Vitamin D

Indexed keywords

ANTIGEN; CALCITRIOL; GAMMA INTERFERON; INTERLEUKIN 17; VITAMIN D; VITAMIN D RECEPTOR;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CROHN DISEASE; CYTOKINE PRODUCTION; DENDRITIC CELL; DIETARY INTAKE; GRAFT REJECTION; HOST RESISTANCE; HUMAN; INFECTION; INFLAMMATORY BOWEL DISEASE; LYMPHOCYTE PROLIFERATION; NONHUMAN; SUN EXPOSURE; SUNLIGHT; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; VITAMIN D DEFICIENCY;

CD8 T CELLS; INFLAMMATORY BOWEL DISEASES; TH17; VITAMIN D;

ANIMALS; CALCITRIOL; HUMANS; INFLAMMATORY BOWEL DISEASES; LYMPHOCYTE ACTIVATION; RECEPTORS, CALCITRIOL; T-LYMPHOCYTES;

EID: 84901506266     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12408     Document Type: Article

References (46)

1. Bhalla, A.K., E.P. Amento, T.L. Clemens, et al. 1983. Specific high-affinity receptors for 1, 25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J. Clin. Endocrinol. Metab. 57: 1308-1310.
2. Provvedini, D.M., C.D. Tsoukas, L.J. Deftos & S.C. Manolagas 1983. 1, 25-dihydroxyvitamin D3 receptors in human leukocytes. Science 221: 1181-1183.
3. Veldman, C.M., M.T. Cantorna & H.F. DeLuca 2000. Expression of 1, 25-dihydroxyvitamin D(3) receptor in the immune system. Arch. Biochem. Biophys. 374: 334-338.
4. Rigby, W.F., T. Stacy & M.W. Fanger 1984. Inhibition of T lymphocyte mitogenesis by 1, 25-dihydroxyvitamin D3 (calcitriol). J. Clin. Invest. 74: 1451-1455.
5. Tsoukas, C.D., D.M. Provvedini & S.C. Manolagas 1984. 1, 25-dihydroxyvitamin D3: a novel immunoregulatory hormone. Science 224: 1438-1440.
6. Rigby, W.F., S. Denome & M.W. Fanger 1987. Regulation of lymphokine production and human T lymphocyte activation by 1, 25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J. Clin. Invest. 79: 1659-1664.
7. Tang, J. et al. 2009. Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J. Immunol. 182: 4624-4632.
8. Zhu, Y., B.D. Mahon, M. Froicu & M.T. Cantorna 2005. Calcium and 1alpha, 25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Eur. J. Immunol. 35: 217-224.
9. Joshi, S. et al. 2011. 1, 25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol. Cell. Biol. 31: 3653-3669.
10. Barrat, F.J. et al. 2002. in vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195: 603-616.
11. Boonstra, A. et al. 2001. 1alpha, 25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J. Immunol. 167: 4974-4980.
12. Sigmundsdottir, H. et al. 2007. DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat. Immunol. 8: 285-293.
13. Penna, G. & L. Adorini 2000. 1 Alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 164: 2405-2411.
14. Griffin, M.D. et al. 2001. Dendritic cell modulation by 1alpha, 25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 98: 6800-6805.
15. Hugot, J.P. 2004. Inflammatory bowel disease: a complex group of genetic disorders. Best Pract. Res. Clin. Gastroenterol. 18: 451-462.
16. Molodecky, N.A. & G.G. Kaplan 2010. Environmental risk factors for inflammatory bowel disease. Gastroenterol. Hepatol. 6: 339-346.
17. Sartor, R.B. 2004. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126: 1620-1633.
18. Sellon, R.K. et al. 1998. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 66: 5224-5231.
19. Nerich, V. et al. 2011. Low exposure to sunlight is a risk factor for Crohn's disease. Aliment. Pharm. Therap. 33: 940-945.
20. Driscoll, R.H., Jr., S.C. Meredith, M. Sitrin & I.H. Rosenberg 1982. Vitamin D deficiency and bone disease in patients with Crohn's disease. Gastroenterology 83: 1252-1258.
21. Mouli, V.P. & A.N. Ananthakrishnan 2014. Review article: vitamin D and inflammatory bowel diseases. Aliment. Pharm. Therap. 39: 125-136.
22. Cantorna, M.T., C. Munsick, C. Bemiss & B.D. Mahon 2000. 1, 25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J. Nutr. 130: 2648-2652.
23. Zella, J.B., L.C. McCary & H.F. DeLuca 2003. Oral administration of 1, 25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus. Arch. Biochem. Biophys. 417: 77-80.
24. Cantorna, M.T., C.E. Hayes & H.F. DeLuca 1996. 1, 25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 93: 7861-7864.
25. Froicu, M. et al. 2003. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol. Endocrinol. 17: 2386-2392.
26. Froicu, M. & M.T. Cantorna 2007. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC immunol. 8: 5.
27. Yang, L. et al. 2013. Therapeutic effect of vitamin d supplementation in a pilot study of Crohn's patients. Clin. Transl. Gastroenterol. 4: e33.
28. Munger, K.L., L.I. Levin, B.W. Hollis, et al. 2006. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296: 2832-2838.
29. Muller, K. et al. 1995. Vitamin D3 metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus. Clin. Rheumatol. 14: 397-400.
30. Zipitis, C.S. & A.K. Akobeng 2008. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch. Dis. Child. 93: 512-517.
31. Lemire, J.M., A. Ince & M. Takashima 1992. 1, 25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice. Autoimmunity 12: 143-148.
32. Bouma, G. & W. Strober 2003. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3: 521-533.
33. Abraham, C. & J. Cho 2009. Interleukin-23/Th17 pathways and inflammatory bowel disease. Inflamm. Bowel Dis. 15: 1090-1100.
34. Maul, J. et al. 2005. Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology 128: 1868-1878.
35. Ooi, J.H., J. Chen & M.T. Cantorna 2012. Vitamin D regulation of immune function in the gut: why do T cells have vitamin D receptors? Mol. Aspects Med. 33: 77-82.
36. Bruce, D., S. Yu, J.H. Ooi & M.T. Cantorna 2011. Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling. Int. Immunol. 23: 519-528.
37. Yu, S., D. Bruce, M. Froicu, et al. 2008. Failure of T cell homing, reduced CD4/CD8alphaalpha intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice. Proc. Natl. Acad. Sci. U. S. A. 105: 20834-20839.
38. Yu, S. & M.T. Cantorna 2008. The vitamin D receptor is required for iNKT cell development. Proc. Natl. Acad. Sci. U. S. A. 105: 5207-5212.
39. Steinhoff, U. et al. 1999. Autoimmune intestinal pathology induced by hsp60-specific CD8 T cells. Immunity 11: 349-358.
40. - T cells and inhibit both T-cell proliferation and CTL function. Hum. Immunol. 65: 142-156.
41. + T cells and development of CD8 mediated gastrointestinal inflammation. BMC Immunol. 15: 6.
42. Cantorna, M.T. et al. 1998. 1, 25-Dihydroxyvitamin D3 prolongs graft survival without compromising host resistance to infection or bone mineral density. Transplantation 66: 828-831.
43. Bruce, D., J.P. Whitcomb, A. August, et al. 2009. Elevated non-specific immunity and normal Listeria clearance in young and old vitamin D receptor knockout mice. Int. Immunol. 21: 113-122.
44. Whitcomb, J.P. et al. 2012. The role of vitamin D and vitamin D receptor in immunity to leishmania major infection. J. Parasitol. Res. 2012: 134645.
45. Mahon, B.D., A. Wittke, V. Weaver & M.T. Cantorna 2003. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J. Cell. Biochem. 89: 922-932.
46. + T cells but not macrophages express the vitamin D 1alpha-hydroxylase. J. Nutr. Biochem. 25: 58-65.